e-learning
resources
Vienna 2009
Wednesday, 16.09.2009
Sustainability in treatment of COPD patients according to economics and quality of care
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pharmaceutical cost of treatment in Greek COPD outpatients
C. Dimitropoulos, T. Tsoutsouras, M. Ntaganou, I. Kostara, G. Alexias, I. Ntanos (Athens, Greece)
Source:
Annual Congress 2009 - Sustainability in treatment of COPD patients according to economics and quality of care
Session:
Sustainability in treatment of COPD patients according to economics and quality of care
Session type:
Oral Presentation
Number:
4653
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Dimitropoulos, T. Tsoutsouras, M. Ntaganou, I. Kostara, G. Alexias, I. Ntanos (Athens, Greece). Pharmaceutical cost of treatment in Greek COPD outpatients. Eur Respir J 2009; 34: Suppl. 53, 4653
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Risk factors of adverse outcome after acute hospitalization in Idiopathic Pulmonary Fibrosis (IPF)
Related content which might interest you:
Pharmacist’s time spending to manage patients with asthma or COPD in an outpatient clinic in Thailand
Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care
Year: 2015
Cost of asthma in patients treated with national asthma guideline in Turkey
Source: Eur Respir J 2003; 22: Suppl. 45, 481s
Year: 2003
The DACCORD study: Real-life COPD outpatient treatment with long-acting bronchodilators in Germany
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013
Safety and efficacy of sputum induction in COPD patients
Source: Annual Congress 2013 –Respiratory nursing care: assessment, interventions and education
Year: 2013
Reason for non-compliance to inhaled medications among adult patients of asthma and COPD attending outpatient department in a tertiary care hospital
Source: International Congress 2016 – Asthma management in primary care
Year: 2016
Drugs prescribed to patients with asthma and COPD before they present to tertiary care hospitals in Trivandrum, India
Source: International Congress 2019 – Epidemiology of airway diseases in primary care
Year: 2019
Prescribing patterns for UK patients commencing first maintenance therapy for COPD
Source: International Congress 2014 – COPD markers
Year: 2014
Non fulfillment adherence in a Czech outpatient department serving COPD and astma patients in one year
Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients?
Year: 2017
The drug costs associated with COPD prescription medicine in Denmark
Source: Annual Congress 2012 - Looking at the cost effectiveness of asthma and COPD treatment by novel drugs and improved management
Year: 2012
Real-world prescribing patterns among newly diagnosed COPD patients receiving ICS: An analysis of UK patient dataset
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014
Effect of COPD medications on exacerbation rates in a real-life COPD patient cohort - data from the Czech Multicenter Research Database of COPD.
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020
Dual bronchodilation in real-life COPD management: analysis of patients’ characteristics enrolled in COPD Registry in Russia
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020
Variability of hospital resources for acute care of COPD patients: the European COPD Audit
Source: Eur Respir J 2014; 43: 754-762
Year: 2014
Prevalence and goals in the managing of COPD patients in COPD-school
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Effectiveness of rehabilitation in COPD outpatients with comorbidities
Source: Annual Congress 2009 - Are outcome measures useful to predict success in rehabilitation and the care of patients with chronic respiratory disease
Year: 2009
Effectiveness of self-treatment of exacerbations in COPD patients: Two-year follow-up of the COPE-II study
Source: International Congress 2014 – Best abstracts in rehabilitation and chronic care (sponsored by MOTEK Medical)
Year: 2014
Cormorbidities and ventilator therapy impact on mortality of COPD patients in German hospitals - an analysis of ICD statistics
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014
The ICE study, Italian costs for exacerbations in COPD: a project of the Italian Association for COPD
Source: Annual Congress 2003 - Outcome of acute exacerbations in COPD
Year: 2003
National clinical audit for hospitalised exacerbations of COPD
Source: ERJ Open Res, 6 (3) 00208-2020; 10.1183/23120541.00208-2020
Year: 2020
Application of the COMCOLD comorbidity index to a UK primary care COPD cohort
Source: International Congress 2015 – Diagnosing and management of COPD in primary care
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept